Citations

Showing 10 of 108104 citations.

High-Resolution Mass Spectrometry for the Measurement of PTH and PTH Fragments: Insights into PTH Physiology and Bioactivity
Ulmer, Candice Z. , Kritmetapak, Kittrawee , Vesper, Hubert W. , Kumar, Rajiv , Kumar, Rajiv , Singh, Ravinder J.

Mayo Clinic

Journal of the American Society of Nephrology | April 8, 2022 | Volume: 33 | Issue: 8 | Pages: 1448-1458

10.1681/asn.2022010036 | PMID 35396262 Get It

Full-length parathyroid hormone (PTH 1–84) is crucial for the regulation of calcium and phosphate homeostasis and bone remodeling. PTH 1–84 is metabolized into various PTH fragments, which are measured with varying levels of efficiency by PTH immunoassays. These PTH fragments, which increase in serum as CKD progresses, could potentially modulate the effects of PTH 1–84 and contribute to CKD-associated bone disorders. To obtain a true biologic representation of total PTH bioactivity, it is necessary to measure not only PTH 1–84 but also PTH fragments that are present in circulation. Traditional second-generation PTH immunoassays collectively measure PTH 1–84, PTH fragments, and post-translationally modified PTH 1–84, making it difficult to accurately predict the character of underlying renal osteodystrophy. This review highlights current advances in methods available for PTH measurement and the clinical relevance of PTH fragments in CKD. We emphasize the usefulness of mass spectrometry as a potential reference method for PTH measurement.
Immunotherapy beyond cellular therapy in follicular lymphoma: A case of complete remission after failure of two CAR‐T
Kase, Adam M. , Kharfan‐Dabaja, Mohamed A. , Donaldson, Andrew , Elliott, Jamie, Sher, Taimur , Elliott, Jamie

Mayo Clinic

Clinical Case Reports | April 8, 2022 | Volume: 10 | Issue: 4 | Pages: No page available

10.1002/ccr3.5572 | PMID 35425600 Get It

AbstractPatients with relapsed follicular lymphoma who do not respond to CAR‐T have a poor outcome. We present a case of refractory follicular lymphoma who relapsed after two CAR‐T infusions and achieved a complete remission after treatment with obinutuzumab and lenalidomide. This represents a promising treatment option in the post‐CAR‐T setting.
Utility of a smartphone application in assessing palmar circulation prior to radial artery harvesting for coronary artery bypass grafting: rationale and design of the randomised CAPITAL iRADIAL-CABG trial
Goh, Cheng Yee , Parlow, Simon , Santo, Pietro Di , Jung, Richard G. , Ahmed, Zeeshan , Verreault‐Julien, Louis , Kuhar, Peter , Al‐Atassi, Talal , Toeg, Hadi , Bernick, Jordan , Wells, George A. , Hibbert, Benjamin , Hibbert, Benjamin , Simard, Trevor , Chan, Vincent , Ruel, Marc

Mayo Clinic

BMJ Open | April 8, 2022 | Volume: 12 | Issue: 4 | Pages: e055580

10.1136/bmjopen-2021-055580 | PMID 35396289 Get It

Introduction There is emerging evidence supporting the use of the radial artery (RA) as a preferred secondary conduit for coronary artery bypass grafting (CABG) as it is associated with higher rates of graft patency at 5 years when compared with saphenous vein grafts (SVG). The modified Allen’s test (MAT) is traditionally regarded as the standard of care in the assessment of ulnar artery (UA) patency prior to RA harvesting. Unfortunately, due to high false-positive rates, a substantial number of pre-CABG patients are found to have an abnormal MAT despite normal UA patency, resulting in inappropriate exclusion from RA harvesting. The SVG is generally used in its place when this occurs, resulting in potentially lower rates of long-term graft patency. Methods and analysis The CAPITAL iRADIAL-CABG trial is currently enrolling participants 18 years of age or older undergoing CABG for whom the treating physician is considering the use of an RA conduit. Eligible patients will be randomised in a 1:1 fashion to MAT or smartphone-based photoplethysmography application assessment to assess collateral palmar circulation prior to RA harvesting. The primary outcome of the trial is the use of the RA as a conduit during CABG. The primary safety outcome is postoperative palmar ischaemia as determined by clinical assessment or requirement of vascular intervention. Secondary outcomes include vascular complications, early graft failure, need for rescue percutaneous coronary intervention during the index hospitalisation and a composite cardiovascular outcome of myocardial infarction, stroke and cardiovascular death prior to discharge from hospital. A total of 236 participants are planned to be recruited. Ethics and dissemination The study was approved by the Ottawa Heart Science Network Research Ethics Board (approval number 20180865-01H). The study results will be disseminated via conference presentations and peer-reviewed publications. Trial registration number NCT03810729.
Post-COVID-19 syndrome: persistent neuroimaging changes and symptoms 9 months after initial infection
Grach, Stephanie L. , Ganesh, Ravindra , Messina, Steven A. , Hurt, Ryan T. , Ganesh, Ravindra , Grach, Stephanie L

Mayo Clinic

BMJ Case Reports | April 8, 2022 | Volume: 15 | Issue: 4 | Pages: e248448

10.1136/bcr-2021-248448 | PMID 35396239 Get It

A previously healthy and active middle-aged woman acquired COVID-19 as an occupational exposure with subsequent persistent post-COVID-19 symptoms including headache, dyspnoea on exertion, chest pressure, tachycardia, anosmia, parosmia, persistent myalgia, vertigo, cognitive decline and fatigue. She presented to a tertiary medical centre for further evaluation after 9 months of persistent symptoms and had a largely unremarkable workup with the exception of a persistently elevated monocyte chemoattractant protein 1, blunted cardiovagal response and non-specific scattered areas of low-level hypometabolism at the bilateral frontal, left precuneus, occipital and parietal regions on PET scan.
Diversity, Equity, and Inclusion Among Anesthesiology Trainees
Patel, Shyam , Lin, Keldon K. , Milam, Adam J. , Yu, Soojie , Raynor, Gwendolyn, Narjeet, Khurmi, Verdiner, Ricardo , Girardo, Marlene , Misra, Lopa , Milam, Adam J

Mayo Clinic

Women's Health Reports | April 8, 2022 | Volume: 3 | Issue: 1 | Pages: 414-419

10.1089/whr.2021.0123 | PMID 35559355 Get It

Technical note: Evaluation of artificial 120‐kilovolt computed tomography images for radiation therapy applications
Tao, Shengzhen , Michalak, Gregory J. , McCollough, C, Hu, Yanle , McCollough, Cynthia, Gong, Hao, Leng, Shuai

Mayo Clinic

Medical Physics | April 8, 2022 | Volume: 49 | Issue: 6 | Pages: 3683-3691

10.1002/mp.15592 | PMID 35394074 Get It

AbstractPurposeThe purpose of this work is to evaluate the scaled computed tomography (CT) number accuracy of an artificial 120 kV reconstruction technique based on phantom experiments in the context of radiation therapy planning.MethodsAn abdomen‐shaped electron density phantom was scanned on a clinical CT scanner capable of artificial 120 kV reconstruction using different tube potentials from 70 to 150 kV. A series of tissue‐equivalent phantom inserts (lung, adipose, breast, solid water, liver, inner bone, 30%/50% CaCO3, cortical bone) were placed inside the phantom. Images were reconstructed using a conventional quantitative reconstruction kernel as well as the artificial 120 kV reconstruction kernel. Scaled CT numbers of inserts were measured from images acquired at different kVs and compared with those acquired at 120 kV, which were deemed as the ground truth. The relative error was quantified as the percentage deviation of scaled CT numbers acquired at different tube potentials from their ground truth values acquired at 120 kV.ResultsScaled CT numbers measured from images reconstructed using the conventional reconstruction demonstrated a strong kV‐dependence. The relative error in scaled CT numbers ranged from 0.6% (liver insert) to 31.1% (cortical bone insert). The artificial 120 kV reconstruction reduced the kV dependence, especially for bone tissues. The relative error in scaled CT number was reduced to 0.4% (liver insert) and 2.6% (30% CaCO3 insert) using this technique. When tube potential selection was limited to the range of 90 to 150 kV, the relative error was further restrained to <1.2% for all tissue types.ConclusionPhantom results demonstrated that using the artificial 120 kV technique, it was feasible to acquire raw projection data at the desired tube potential and then reconstruct images with scaled CT numbers comparable to those obtained directly at 120 kV. In radiotherapy applications, this technique may allow optimization of tube potential without complicating clinical workflow by eliminating the necessity of maintaining multiple sets of CT calibration curves.
Incidence, prevalence and mortality of chronic periaortitis: a population-based study
Ghaffar, Umar , Duong, Stephanie Q. , Crowson, Cynthia S. , Burke, Michelle, Potretzke, Aaron M. , Burke, Michelle M, Viers, Boyd R. , Bjarnason, Haraldur , Koster, Matthew J. , Warrington, Kenneth J.

Mayo Clinic

Clinical and Experimental Rheumatology | April 8, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.55563/clinexprheumatol/0v8l4j | PMID 35200130 Get It

Accuracy of noninvasive fibrosis scores in predicting advanced fibrosis in pediatric patients after liver transplantation
Habash, Nawras W. , Ezaizi, Yamen, Kak, Ibrahim, Selvakumar, Praveen Kumar Conjeevaram , López, Rocío , Alkhouri, Naim , Kabbany, Mohammad Nasser , Habash, Nawras

Mayo Clinic

Pediatric Transplantation | April 8, 2022 | Volume: 26 | Issue: 5 | Pages: No page available

10.1111/petr.14279 | PMID 35393654 Get It

AbstractBackgroundLiver biopsy is the gold standard to stage fibrosis in liver disease. Several scoring systems have been studied to predict advanced fibrosis in liver disease. Those scores have not been validated in pediatric liver transplant patients.AimEvaluate the performance of three fibrosis scores (FSc) in assessing the presence of advanced fibrosis (AF) in children after orthotopic liver transplantation (OLT).MethodsPatients < 20 years of age who underwent liver biopsy post‐OLT with laboratory values within 1 month of the biopsy were included. Fibrosis was determined by an experienced pathologist (F0‐4). We defined AF as F3‐4. The following FSc were calculated: AST/ALT ratio, APRI, and FIB‐4 index. Receiver operating characteristic curve analysis was done to assess the FSc performance in predicting AF.ResultsA total of 232 biopsies were analyzed, of those 42 (18.1%) showed AF (F3‐4). FIB‐4 was significantly higher in patients with AF compared to those without AF [median value of 1.1 [0.7, 3.0] and 0.6 [0.2, 1.4], respectively (p = .02)]; however, FIB‐4 had satisfactory accuracy to diagnose AF with significant overlap and AUC of 0.68 (CI 0.56–0.81). Cutoff points of 0.2 and 3.03 were used to rule in and rule out AF, respectively. AST/ALT and APRI were not significantly different between patients with and without AF.ConclusionEven though FIB‐4 had satisfactory accuracy in detecting AF in pediatric transplant patients, noninvasive hepatic FSc developed in adults still performed poorly. Our results highlight the need to develop a reliable pediatric FSc.
Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective
Aggarwal, Neelum T. , Vila‐Castelar, Clara , Brugulat‐Serrat, Anna , Foldi, Nancy S. , Gilsanz, Paola , Li, Wei , McManus, Alison J. , Lent, Debora Melo van , Milani, Sadaf Arefi , Shaaban, C. Elizabeth , Stites, Shana D. , Trani, Jean‐Francoise, Turner, Arlener D. , Vonk, Jet M. J. , Quiroz, Yakeel T. , Group, for the Diversity and Disparity Professional Interest Area Sex and Gender Special Interest, Mielke, Michelle M. , Agarwal, Puja , Arenaza‐Urquijo, Eider M. , Brett, Benjamin L. , DuBose, Lyndsey Elisabeth , Eikelboom, Willem S. , Flatt, Jason D. , Franzen, Sanne , Sundermann, Erin E. , Suryadevara, Vidyani , Babulal, Ganesh M. , Group, for the Diversity and Disparity Professional Interest Area Sex and Gender Special Interest

Mayo Clinic

Alzheimer's & Dementia | April 8, 2022 | Volume: 18 | Issue: 12 | Pages: 2707-2724

10.1002/alz.12662 | PMID 35394117 Get It

Abstract Sex or gender differences in the risk of Alzheimer's disease and related dementias (ADRD) differ by world region, suggesting that there are potentially modifiable risk factors for intervention. However, few epidemiological or clinical ADRD studies examine sex differences; even fewer evaluate gender in the context of ADRD risk. The goals of this perspective are to: (1) provide definitions of gender, biologic sex, and sexual orientation. and the limitations of examining these as binary variables; (2) provide an overview of what is known with regard to sex and gender differences in the risk, prevention, and diagnosis of ADRD; and (3) discuss these sex and gender differences from a global, worldwide perspective. Identifying drivers of sex and gender differences in ADRD throughout the world is a first step in developing interventions unique to each geographical and sociocultural area to reduce these inequities and to ultimately reduce global ADRD risk. Highlights The burden of dementia is unevenly distributed geographically and by sex and gender. Scientific advances in genetics and biomarkers challenge beliefs that sex is binary. Discrimination against women and sex and gender minority (SGM) populations contributes to cognitive decline. Sociocultural factors lead to gender inequities in Alzheimer's disease and related dementias (ADRD) worldwide.
Optimal false discovery rate control for large scale multiple testing with auxiliary information
Cao, Hongyuan , Zhang, Xianyang , Chen, Jun

Mayo Clinic

The Annals of Statistics | April 8, 2022 | Volume: 50 | Issue: 2 | Pages: No page available

10.1214/21-aos2128 | PMID 37138896 Get It